126 related articles for article (PubMed ID: 30224542)
1. Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining.
de Boer DV; Brink A; Buijze M; Stigter-van Walsum M; Hunter KD; Ylstra B; Bloemena E; Leemans CR; Brakenhoff RH
Mol Cancer Res; 2019 Jan; 17(1):120-130. PubMed ID: 30224542
[TBL] [Abstract][Full Text] [Related]
2. Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers.
van Zeeburg HJ; Graveland AP; Brink A; Nguyen M; Leemans CR; Bloemena E; Braakhuis BJ; Brakenhoff RH
Head Neck; 2013 Apr; 35(4):568-74. PubMed ID: 22714984
[TBL] [Abstract][Full Text] [Related]
3. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition.
van Harten AM; de Boer DV; Martens-de Kemp SR; Buijze M; Ganzevles SH; Hunter KD; Leemans CR; van Beusechem VW; Wolthuis RMF; de Menezes RX; Brakenhoff RH
Sci Rep; 2020 Feb; 10(1):2330. PubMed ID: 32047167
[TBL] [Abstract][Full Text] [Related]
5. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
7. Progression of microsatellite instability from premalignant lesions to tumors of the head and neck.
Ha PK; Pilkington TA; Westra WH; Sciubba J; Sidransky D; Califano JA
Int J Cancer; 2002 Dec; 102(6):615-7. PubMed ID: 12448003
[TBL] [Abstract][Full Text] [Related]
8. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
9. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression.
Huang Q; Yu GP; McCormick SA; Mo J; Datta B; Mahimkar M; Lazarus P; Schäffer AA; Desper R; Schantz SP
Genes Chromosomes Cancer; 2002 Jun; 34(2):224-33. PubMed ID: 11979556
[TBL] [Abstract][Full Text] [Related]
10. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.
Braakhuis BJ; Leemans CR; Brakenhoff RH
Semin Cancer Biol; 2005 Apr; 15(2):113-20. PubMed ID: 15652456
[TBL] [Abstract][Full Text] [Related]
11. Screening for oral precancer with noninvasive genetic cytology.
Bremmer JF; Graveland AP; Brink A; Braakhuis BJ; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
Cancer Prev Res (Phila); 2009 Feb; 2(2):128-33. PubMed ID: 19174582
[TBL] [Abstract][Full Text] [Related]
12. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
[TBL] [Abstract][Full Text] [Related]
13. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ
Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739
[TBL] [Abstract][Full Text] [Related]
14. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
15. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis.
Youssef EM; Lotan D; Issa JP; Wakasa K; Fan YH; Mao L; Hassan K; Feng L; Lee JJ; Lippman SM; Hong WK; Lotan R
Clin Cancer Res; 2004 Mar; 10(5):1733-42. PubMed ID: 15014026
[TBL] [Abstract][Full Text] [Related]
17. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene.
Tabor MP; van Houten VM; Kummer JA; Vosjan MJ; Vlasblom R; Snow GB; Leemans CR; Braakhuis BJ; Brakenhoff RH
Genes Chromosomes Cancer; 2002 Feb; 33(2):168-77. PubMed ID: 11793443
[TBL] [Abstract][Full Text] [Related]
18. The molecular biology of mucosal field cancerization of the head and neck.
Ha PK; Califano JA
Crit Rev Oral Biol Med; 2003; 14(5):363-9. PubMed ID: 14530304
[TBL] [Abstract][Full Text] [Related]
19. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
20. Head and neck cancer and precancer: can we use molecular genetics to make better predictions?
Partridge M
Ann R Coll Surg Engl; 1999 Jan; 81(1):1-11. PubMed ID: 10325677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
